1. Home
  2. SVRA vs GCT Comparison

SVRA vs GCT Comparison

Compare SVRA & GCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVRA
  • GCT
  • Stock Information
  • Founded
  • SVRA 2007
  • GCT 2019
  • Country
  • SVRA United States
  • GCT United States
  • Employees
  • SVRA N/A
  • GCT N/A
  • Industry
  • SVRA Biotechnology: Pharmaceutical Preparations
  • GCT Catalog/Specialty Distribution
  • Sector
  • SVRA Health Care
  • GCT Consumer Discretionary
  • Exchange
  • SVRA Nasdaq
  • GCT Nasdaq
  • Market Cap
  • SVRA 528.3M
  • GCT 502.5M
  • IPO Year
  • SVRA N/A
  • GCT 2022
  • Fundamental
  • Price
  • SVRA $2.06
  • GCT $18.24
  • Analyst Decision
  • SVRA Buy
  • GCT Buy
  • Analyst Count
  • SVRA 7
  • GCT 2
  • Target Price
  • SVRA $7.57
  • GCT $20.50
  • AVG Volume (30 Days)
  • SVRA 2.5M
  • GCT 511.5K
  • Earning Date
  • SVRA 08-11-2025
  • GCT 08-05-2025
  • Dividend Yield
  • SVRA N/A
  • GCT N/A
  • EPS Growth
  • SVRA N/A
  • GCT 19.58
  • EPS
  • SVRA N/A
  • GCT 3.07
  • Revenue
  • SVRA N/A
  • GCT $1,181,871,000.00
  • Revenue This Year
  • SVRA N/A
  • GCT $1.98
  • Revenue Next Year
  • SVRA N/A
  • GCT $6.50
  • P/E Ratio
  • SVRA N/A
  • GCT $5.94
  • Revenue Growth
  • SVRA N/A
  • GCT 42.89
  • 52 Week Low
  • SVRA $1.89
  • GCT $11.17
  • 52 Week High
  • SVRA $5.11
  • GCT $34.28
  • Technical
  • Relative Strength Index (RSI)
  • SVRA 34.43
  • GCT 54.92
  • Support Level
  • SVRA $2.13
  • GCT $17.80
  • Resistance Level
  • SVRA $2.49
  • GCT $18.59
  • Average True Range (ATR)
  • SVRA 0.15
  • GCT 0.61
  • MACD
  • SVRA -0.01
  • GCT -0.21
  • Stochastic Oscillator
  • SVRA 8.41
  • GCT 43.04

About SVRA Savara Inc.

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

About GCT GigaCloud Technology Inc

GigaCloud Technology Inc provides end-to-end and B2B e-commerce solutions for large parcel merchandise. Its B2B e-commerce platform, which is referred to as the GigaCloud Marketplace, integrates everything from discovery, payments, and logistics tools into one easy-to-use platform. It offers online and offline integrated cross-border transaction and delivery services for furniture and large merchandise. Its marketplace seamlessly connects manufacturers in Asia, with resellers in the U.S., Asia, and Europe, to execute cross-border transactions with confidence, speed, and efficiency. It offers a truly comprehensive solution that transports products from the manufacturer's warehouse to end customers, all at one fixed price.

Share on Social Networks: